SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-020450
Filing Date
2024-05-06
Accepted
2024-05-06 06:38:11
Documents
90
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adc-20240331.htm   iXBRL 10-Q 1063985
2 EX-31.1 ex311-ceocertification302q.htm EX-31.1 9690
3 EX-31.2 ex312-cfocertification302q.htm EX-31.2 9566
4 EX-32.1 ex321-ceocertification906q.htm EX-32.1 4535
5 EX-32.2 ex322-cfocertification906q.htm EX-32.2 4537
11 adc-20240331_g1.jpg GRAPHIC 9084
  Complete submission text file 0001628280-24-020450.txt   6038076

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adc-20240331.xsd EX-101.SCH 47740
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adc-20240331_cal.xml EX-101.CAL 76055
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adc-20240331_def.xml EX-101.DEF 183596
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adc-20240331_lab.xml EX-101.LAB 560708
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adc-20240331_pre.xml EX-101.PRE 413355
94 EXTRACTED XBRL INSTANCE DOCUMENT adc-20240331_htm.xml XML 741755
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39071 | Film No.: 24915473
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)